DEATH CAUSES AND THEIR PREDICTION IN PATIENTS WITH THE ST SEGMENT ELEVATION ACUTE CORONARY SYNDROME AND PRE-HOSPITAL THROMBOLYSIS

Author:

Morozov S. N.1,Fedorov A. I.2,Loskutova K. S.3,Vertkin A. L.1

Affiliation:

1. A.I. Evdokimov Moscow State Medico-Stomatological University, Moscow

2. M.K. Amosov North-East Federal University, Yakutsk

3. Yakutsk Division, Siberian Branch, Russian Academy of Medical Sciences, Yakutsk

Abstract

Aim.To assess effectiveness and safety of pre-hospital medical treatment in patients with acute coronary syndrome and ST segment elevation (ST-ACS) who are undergoing thrombolytic therapy (TLT); to identify TLT complications and the methods for their prediction.Material and methods.In total, the pre-hospital TLT effectiveness was assessed in 237 patients. The comparison group included 274 patients who did not undergo TLT, due to various reasons. The causes of death by Day 7–10 were analysed.Results.The leading cause of death was cardiogenic shock. In addition, in the main group, indirect myocardial rupture was a cause of death more often than in the comparison group (28% vs. 5,3%). Indirect myocardial rupture was associated with haemorrhagic complications of pre-hospital TLT. The proposed method for predicting TLT complications is based on the TIMI scale: 1–4 points suggest TLT safety; 4–5 points correspond to a higher risk of external myocardial rupture (11,6%), which implies the need to perform TLT under control of blood coagulation parameters; and ≥6 points denote the need to avoid pre-hospital TLT and use a mechanic reperfusion strategy.Conclusion.Among ST-ACS patients, mortality levels were 20,9%, which was 2,4 times higher than in the comparison group. In the main group, the morphological data obtained at autopsy demonstrated hemorrhagic myocardial transformation, which was associated with the high risk of indirect myocardial rupture (28,1%). In patients with pre-existing arterial hypertension and with the time from the ST-ACS onset of 2–3 hours, the risk of indirect myocardial rupture should be predicted, based on the TIMI scale. This will facilitate more effective assessment of the systemic TLT complication risk and selection of the optimal reperfusion strategy. 

Publisher

Silicea - Poligraf, LLC

Subject

Cardiology and Cardiovascular Medicine

Reference18 articles.

1. Ruda MY. What you need to know doctor about thrombolysis in myocardial infarction. Heart 2002; 1: 9–12. Russian (Ruda M. Ya. Chto nuzhno znat' praktikuyushchemu vrachu o tromboliticheskoi terapii pri infarkte miokarda. Serdtse 2002; 1: 9–12).

2. Goloborodko VI. Thrombolytic therapy of myocardial infarction — a modern approach to the problem. Ukrainian J Cardiology 2006; 1: 5–21. Russian (Goloborod'ko B. I. Tromboliticheskaya terapiya infarkta miokarda — sovremennyi vzglyad na problemu. Ukrain kardiolog zh 2006; 1: 5–21).

3. Goldstein P, Wiel E. Management of prehospital thrombolytic therapy in ST-segment elevation acute coronary syndrome (<12 hours). Minerva Anestesiol 2005; 6: 297–302.

4. Fresco C, Fioretti PM. Early prehospital thrombolysis in acute myocardial infarct: a moral obligation? Ital J Heart 2003; 2: 102–11.

5. Al-Anee K, Al-Ani A, Henriksen M. Mortality after acute coronary syndrome. Tidsskr Nor Laegeforen 2007; 12: 1628–30.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3